Clene (CLNN)
(Delayed Data from NSDQ)
$0.34 USD
-0.01 (-1.90%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.34 0.00 (0.03%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Price, Consensus and EPS Surprise
CLNN 0.34 -0.01(-1.90%)
Will CLNN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CLNN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CLNN
Clene Inc. (CLNN) Reports Q4 Loss, Tops Revenue Estimates
Dentsply International (XRAY) Q4 Earnings and Revenues Beat Estimates
CLNN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates
Ascendis Pharma A/S (ASND) Soars 3.2%: Is Further Upside Left in the Stock?
Lineage Cell (LCTX) Reports Q2 Loss, Tops Revenue Estimates
Other News for CLNN
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Analysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket